PRF Based Dressing Versus AQUACEL® for Local Treatment of Skin Graft Donor Site

Rambam Health Care Campus

Overview

PRF Based Dressing Versus AQUACEL® for Local Treatment of Skin Graft Donor Site: A Non-Inferiority Trial

A prospective single-blind study, where the evaluator is blinded to the treatment. Each patient will be dressed with both Aquacel® and PRF dressing. Half of the donor site area will be dressed with PRF dressing, and half with Aquacel®. 3 days after surgery the patients will be asked to complete a VAS questionnaire. A week and 2 weeks after surgery, patients will have their dressing changed as in the first treatment, and will answer VAS(9) and bluebelle(10) questionnaires. The wound will be photographed again for follow-up. Three weeks, 6 weeks and 3 months after surgery the scar in the donor area will be evaluated. The photographs will be shown to the blinded evaluator, to evaluate wound healing by epithelialization estimation.

Study Type

INTERVENTIONAL

Allocation

Purpose

TREATMENT

Masking

NONE

Conditions

Treatment of Skin Graft Donor Site

Interventions

Half of the harvested area will be dressed with PRF dressing, and half with Aquacel®.OTHER

Half of the harvested area will be dressed with PRF dressing, and half with Aquacel®.

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: \- Patients with a small burn (2-20% TBSA), who require skin grafting. Exclusion Criteria: * Patients younger than 18 years * Patients refusing hospitalization * Patients with heavily infected wounds, which are the probable cause of bacteremia or sepsis. * Patients with diabetes mellitus or peripheral vascular disease * Patients under treatment of steroids or other immunosuppressing agents * Patients with infectious diseases, i.e., HIV, HCV or HBV. * Patients who are smokers. * Patients with a known allergy to the dressing. * Female patients who are pregnant or nursing, psychiatric patients and soldiers.

Locations (1)

Rambam health care campus

Haifa, Israel

Outcomes

Primary Outcomes

Change of percentage of wound healing after 1 week, 2 weeks and 3 weeks.

Primary variables will be analyzed using ImageJ software.

Time frame: 3 weeks

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.